RNA Regulation of Transcription Factor Activity
RNA对转录因子活性的调节
基本信息
- 批准号:10643894
- 负责人:
- 金额:$ 39.41万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2016
- 资助国家:美国
- 起止时间:2016-09-22 至 2025-06-30
- 项目状态:未结题
- 来源:
- 关键词:AbbreviationsAddressAutomobile DrivingBindingBinding ProteinsBiochemicalBiologicalBiologyCell physiologyCellsChromatinCodeCollaborationsComplexConsensusCrystallizationCuesDNA BindingDNA Binding DomainDataData SetDatabasesDifferentiation and GrowthDouble-Stranded RNAEMSAElectrophoretic Mobility Shift AssayElementsEnhancersEstrogen ReceptorsExhibitsFamilyFingersFluorescence AnisotropyGene ExpressionGene Expression ProfileGene Expression RegulationGenesGenetic Enhancer ElementGenetic TranscriptionGlucocorticoid ReceptorGlucocorticoidsGoalsGrantHMGB Family GeneHormonesIn VitroInvestigationLifeMeasuresMediatingModelingMolecularMolecular ConformationMotivationMusNatureNuclearNuclear Hormone ReceptorsNucleic Acid Regulatory SequencesPlayPrevalenceProcessProgram DescriptionPromoter RegionsProteinsRNARNA BindingRNA Recognition MotifRegulationReportingResearchResolutionResponse ElementsRoleSiteSpecificityStructureTestingThiouridineTranscriptional RegulationUntranslated RNAdesignembryonic stem cellexperimental studygenome-widein vitro activityin vivoinsightmembermutantnew therapeutic targetnovelnucleic acid structurepluripotency factorprogramspromoterreceptor bindingresponsetranscription factortranscriptomeultraviolet
项目摘要
Project Summary/Abstract
Nimble and responsive transcriptional control is central to all processes of life, and hence this process is
regulated at a number of levels. During the last grant period, we discovered a robust, and unexpected, RNA-
binding activity inherent in representative proteins from two major classes of transcriptional factors (TFs): the
pluripotency factor Sox2 of the high mobility group box (HMGB) family and the glucocorticoid nuclear hormone
receptor (GR). Their RNA-binding activity was found to be mediated by their DNA-binding domains and directly
compete with DNA binding to their respective promoter or enhancer sequences. Furthermore, we found that
this activity was structure-specific rather than sequence specific in vitro. Both TFs strongly disfavored binding
ssRNA. Instead, the pluripotency factor Sox2 bound dsRNA regions while GR bound exclusively to RNA
hairpin structures.
These observations raise critical questions regarding the role of TF RNA-binding activity in transcriptional
regulation and provide the direct motivation for the research program described here. Our corroborating
discovery of RNA association of Sox2 in mouse embryonic stem cells confirms that direct RNA binding occurs
in vivo. The next steps are to further define and understand the specificity for the in vivo RNA targets and
determine the impact TF RNA interactions has on the transcriptional program. This includes refining our
understanding of what drives this RNA binding and determine how pervasive the activity is in other TFs.
We have developed an integrated and strategic research program to achieve these goals. Aim 1 capitalizes on
our observation that Sox2 directly interacts with RNAs in cells and develops this critical line of inquiry in GR to
develop a comprehensive RNA interactome including eRNAs. We will investigate whether transcription factors
use their RNA-binding activity to provide an alternate chromatin association strategy that impacts localization
and gene regulation. Finally, we take advantage of our biochemical insights to design and validate DNA- and
RNA-binding separation-of-function mutants, which will allow us to directly measure the impact of loss of RNA
binding on the transcriptome. In Aim 2, we turn to understanding the molecular nature of RNA association to
Sox2 and GR, first through the use of eCLIP strategies to identify consensus binding motifs and second
through high resolution structure determination of TF/RNA complexes. In Aim 3 of this program, we will
establish the generality of these observations to other important transcription factors, both within and beyond
the HMGB and nuclear hormone receptor families, as represented by Sox2 and GR, respectively.
Together, this proposal describes a comprehensive program seeking to determine the extent and role of RNA
binding in modulating the transcriptional program through interaction with classic transcription factors. The
impact of this program is high because understanding the roles of genome-wide pervasive transcription and
how this activity influences diverse cellular processes remains a major unanswered question in biology.
项目总结/摘要
灵活和反应灵敏的转录控制是所有生命过程的核心,因此这一过程是
在多个层面上进行监管。在上一次资助期间,我们发现了一种强大的,意想不到的RNA-
来自两大类转录因子(TF)的代表性蛋白质中固有的结合活性:
高迁移率族蛋白(HMGB)家族的多能性因子Sox 2和糖皮质激素核激素
受体(GR)。发现它们的RNA结合活性是由它们的DNA结合结构域介导的,并且是直接的
与结合到它们各自的启动子或增强子序列的DNA竞争。此外,我们发现,
这种活性在体外是结构特异性的而不是序列特异性的。两种TF均强烈不利于结合
ssRNA。相反,多能性因子Sox 2结合dsRNA区域,而GR仅结合RNA
发夹结构
这些观察结果提出了关于TF RNA结合活性在转录调控中的作用的关键问题。
监管,并为这里描述的研究计划提供直接动力。我们的佐证
在小鼠胚胎干细胞中发现Sox 2的RNA结合证实了直接RNA结合的发生
in vivo.下一步是进一步定义和理解体内RNA靶点的特异性,
确定TF RNA相互作用对转录程序的影响。这包括改进我们的
了解是什么驱动了这种RNA结合,并确定这种活性在其他TF中的普遍程度。
我们已经制定了一个综合和战略研究计划,以实现这些目标。目标1利用
我们观察到Sox 2直接与细胞中的RNA相互作用,并在GR中发展了这一关键的研究路线,
开发包括eRNA在内的全面的RNA相互作用组。我们将研究转录因子是否
利用它们的RNA结合活性提供一种替代的染色质缔合策略,
和基因调控。最后,我们利用我们的生物化学见解来设计和验证DNA,
RNA结合功能分离突变体,这将使我们能够直接测量RNA丢失的影响,
与转录组结合。在目标2中,我们转向理解RNA缔合的分子性质,
Sox 2和GR,首先通过使用eCLIP策略来鉴定共有结合基序,
通过TF/RNA复合物的高分辨率结构测定。在本计划的目标3中,我们将
建立这些观察的一般性,以其他重要的转录因子,无论是内部和外部
HMGB和核激素受体家族,分别以Sox 2和GR为代表。
总之,这项建议描述了一个全面的计划,寻求确定RNA的程度和作用,
通过与经典转录因子的相互作用调节转录程序。的
该计划的影响很大,因为了解全基因组普遍转录的作用,
这种活动如何影响不同的细胞过程仍然是生物学中一个主要的未解之谜。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
DEBORAH S. WUTTKE其他文献
DEBORAH S. WUTTKE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('DEBORAH S. WUTTKE', 18)}}的其他基金
RNA Regulation of Transcription Factor Activity
RNA对转录因子活性的调节
- 批准号:
10796315 - 财政年份:2016
- 资助金额:
$ 39.41万 - 项目类别:
RNA Regulation of Transcription Factor Activity
RNA对转录因子活性的调节
- 批准号:
10471426 - 财政年份:2016
- 资助金额:
$ 39.41万 - 项目类别:
RNA Regulation of Transcription Factor Activity
RNA对转录因子活性的调节
- 批准号:
10316936 - 财政年份:2016
- 资助金额:
$ 39.41万 - 项目类别:
Development of a HTS Assay Targeting End Protection of Telomeres
针对端粒末端保护的 HTS 测定的开发
- 批准号:
7289370 - 财政年份:2007
- 资助金额:
$ 39.41万 - 项目类别:
相似海外基金
Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
- 批准号:
MR/S03398X/2 - 财政年份:2024
- 资助金额:
$ 39.41万 - 项目类别:
Fellowship
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
- 批准号:
2338423 - 财政年份:2024
- 资助金额:
$ 39.41万 - 项目类别:
Continuing Grant
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
- 批准号:
EP/Y001486/1 - 财政年份:2024
- 资助金额:
$ 39.41万 - 项目类别:
Research Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
- 批准号:
MR/X03657X/1 - 财政年份:2024
- 资助金额:
$ 39.41万 - 项目类别:
Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
- 批准号:
2348066 - 财政年份:2024
- 资助金额:
$ 39.41万 - 项目类别:
Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
- 批准号:
AH/Z505481/1 - 财政年份:2024
- 资助金额:
$ 39.41万 - 项目类别:
Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10107647 - 财政年份:2024
- 资助金额:
$ 39.41万 - 项目类别:
EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
- 批准号:
2341402 - 财政年份:2024
- 资助金额:
$ 39.41万 - 项目类别:
Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
- 批准号:
10106221 - 财政年份:2024
- 资助金额:
$ 39.41万 - 项目类别:
EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
- 批准号:
AH/Z505341/1 - 财政年份:2024
- 资助金额:
$ 39.41万 - 项目类别:
Research Grant